Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...
Proving the potential of AI screenings Artificial intelligence may help radiologists spot disease, but throwing the ...
LSEG has today released a preview of findings from the latest LSEG Risk Intelligence global market survey which will be published in its entirety in a white paper “Operating at the Speed of Crime: The ...
Please provide your email address to receive an email when new articles are posted on . Surveillance led to detection of smaller tumors among patients at high risk for pancreatic cancer. Individuals ...
Genmab Relies on IDBS’ ActivityBase XE for Analyzing Results from Its Discovery Activities Therapeutic monoclonal antibodies are the fastest growing segment within the pharmaceutical market. Among ...
The collaboration is aimed at addressing insider threats, sabotage, and other physical risks tied to the expansion of ...
Evidence regarding screening for atrial fibrillation (AF) in asymptomatic adults without a history of TIA/stroke remains insufficient to definitively weigh the potential benefits and harms, according ...
The Healthy @Reader's Digest on MSN
New Data Shows 60% of Patients Don’t Know Where This Critical Body Part Is
This awareness gap could prevent earlier cancer detection, so one expert doctor is sharing crucial details you should know.
LSEG Risk Intelligence and Amazon Web Services release an API to embed compliance checks in transaction workflows without ...
MELVILLE, N.Y.--(BUSINESS WIRE)--Accio Data, the background screening industry’s leading enterprise platform provider, and Intellicheck, Inc. (Nasdaq: IDN), an industry-leading identity company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback